Gland Pharma appoints Shyamakant Giri as CEO
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
He holds a Master’s in Management from the National University of Singapore
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
Dhiraj brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media, Retail, and FMCG
e brings over 27+ years of rich pharmaceutical experience
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Subscribe To Our Newsletter & Stay Updated